News

ISB’s Robert Moritz Lab Receives NIGMS Grant for Trans Proteomic Pipeline

The National Institute Of General Medical Sciences of the NIH has awarded Principal Investigator(s): Eric Deutsch, PhD, and Robert L. Moritz, PhD, a continuing R01 grant GM087221 for the ongoing development of the Trans-Proteomic Pipeline. The award titled “Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry” will continue the work of the ISB flagship proteomics analysis suite of open-source programs that has been downloaded thousands of times by researchers worldwide. The TPP team will continue on its effort of building new tools and teaching researchers (see previous post about ISB's TPP course) from across the globe how to access new statistical validation and cloud-enabled components of the TPP. The grant will provide ISB with direct costs of $287,000 each year for the next 4 years for Deutsch, Luis Mendoza, David Shteynberg and Zhi Sun of the Moritz group to continue this work.

Recent Articles

  • Dr. Jeff Ranish and Dr. Mark Gillespie

    Mysteries of Cell Fate Unlocked with New Measurement and Modeling Techniques 

    In the cellular process of differentiation, information about the concentrations of an important class of proteins residing in a cell’s nucleus has been lacking, a missing link needed for scientists to fully understand how the process works. ISB researchers have quantified this important class of proteins that play a key role in the formation of red blood cells.

  • Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease

    ISB researchers and their collaborators are using systems biology approaches to learn how the malaria parasite is able to transfer to humans via the bite of an infected mosquito. The information they have uncovered may help identify new ways to prevent people from contracting the deadly disease.

  • Andrea Varela-Stokes

    ISB’s Moritz Lab Lands NIH Grant to Study Lyme Disease

    ISB’s Moritz Lab has received research funding totaling nearly $525,000 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to develop “novel peptide based biomarkers for Lyme disease diagnostics.”